H.R. 5725 · 115th Congress
Benefit Evaluation of Safe Treatment Act of 2018
- Stage
- In committee
- Sponsor
- Peter Roskam
- Introduced
- 2018-05-09
- Latest action
- 2018-05-23 · Referred to the Subcommittee on Health.
Summary
Benefit Evaluation of Safe Treatment Act of 2018 or the BEST Act of 2018
This bill requires the Centers for Medicare & Medicaid Services to report on the availability of supplemental health care benefits for the prevention and treatment of substance use disorders under Medicare Advantage (MA) plans, including differences between MA plans for certain individuals with special needs and other MA plans.